David Henry Mack - 01 Jul 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Reporting relationship: President and CEO, Director
Issuer ticker: PMVP
Reported as of: 01 Jul 2025
Net transaction value: -$62,179
SEC form: 4
Accepted by SEC: 03 Jul 2025, 19:48:00 UTC
Prior SEC filing: 05 Mar 2025
Next SEC filing: 29 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert Ticktin, by power of attorney

Key filing fact

David Henry Mack filed Form 4 for PMV Pharmaceuticals, Inc. (PMVP) on 03 Jul 2025.

Key facts

This page summarizes David Henry Mack's Form 4 filing for PMV Pharmaceuticals, Inc. (PMVP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jul 2025, 19:48.

Change

Previous filing in this sequence was filed on 05 Mar 2025.
Current net transaction value: -$62,179.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001341642 Primary reporting owner

Mack David Henry

Relationship: President and CEO, Director
Address: C/O PMV PHARMACEUTICALS, INC., 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON
Signature: /s/ Robert Ticktin, by power of attorney
Signature date: 03 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PMVP transaction

Common Stock

Sale

Transaction value: $62,179
Shares: -58,411
Change %: -9.8%
Price: $1.06
Shares after: 536,133
Date: 01 Jul 2025
Ownership: Direct
Footnotes: F1, F2

PMVP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 165,307
Date: 01 Jul 2025
Ownership: See footnote
Footnotes: F3

PMVP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 147,915
Date: 01 Jul 2025
Ownership: See footnote
Footnotes: F4

PMVP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 56,978
Date: 01 Jul 2025
Ownership: See footnote
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

Footnote F2

Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025.

Footnote F3

The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Footnote F4

The shares are held of record by the Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Footnote F5

The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.